|Slides from the 2016 SRNT Preconference Workshop - Perspectives on Nicotine: Science and Policy|
Following numerous requests for access to the presentations included in the FDA’s pre-conference workshop, Perspectives on Nicotine: Science and Policy, at the SRNT 2016 Annual Meeting, SRNT received permission to post most of the presentations online. We recognize that not all members or meeting attendees could participate in this workshop; therefore, we wanted to make this information broadly available. To view the slides, please click on the presentation title. (Note: only slides that were cleared by presenters for wide dissemination are provided).
This workshop included three parts:
Below is a list of the available presentations:
Ø Perspectives on Nicotine Science and Policy: Are We Having the Right Debate?
Ø Overview of Harms and Risks of Nicotine
Ø What the Public Knows and Believes About Nicotine: Insights from Recent Quantitative and Qualitative Evidence
Ø Long-Term Medicinal Nicotine Use after Smoking Cessation
Ø Poly Tobacco Use among Adults and Use of Medications and Tobacco Products in Quit Attempts: Data from Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study
Ø Is a Rose Called by Any Other Name Still a Rose? Applying the Concepts of Harm Reduction to Tobacco
# # #